Y
Young Jin Suh
Researcher at Kyungpook National University
Publications - 395
Citations - 5032
Young Jin Suh is an academic researcher from Kyungpook National University. The author has contributed to research in topics: Ricci curvature & Jacobi operator. The author has an hindex of 34, co-authored 364 publications receiving 4180 citations. Previous affiliations of Young Jin Suh include UPRRP College of Natural Sciences & St. Vincent's Health System.
Papers
More filters
Journal ArticleDOI
On ruled real hypersurfaces in a complex space form
TL;DR: In this article, a complex n-dimensional Kaehlerian manifold of constant holomorphic sectional curvature c is denoted by Mn(c), which is a complete and simply connected complex space form consisting of a complex projective space PnC, a complex Euclidean space Cn or a complex hyperbolic space HnC according as c>0, c=0 or c<0.
Journal ArticleDOI
Characterizations of the Lorentzian manifolds admitting a type of semi-symmetric metric connection
TL;DR: In this paper, it was proved that a Lorentzian manifold endowed with a semi-symmetric metric connection is a GRW spacetime and characterized the Ricci semisymmetric manifold.
Journal ArticleDOI
Perfect-fluid, generalised Robertson-Walker space-times, and Gray's decomposition
TL;DR: In this article, the Ricci tensor has been shown to have the form of a perfect fluid in all the O(n)-invariant subspaces provided by Gray's decomposition of the gradient of the R tensor.
Journal ArticleDOI
Clinical implication of p53 overexpression in breast cancer patients younger than 50 years with a triple-negative subtype who undergo a modified radical mastectomy.
TL;DR: In this paper, the authors identify the clinicopathological characteristics and prognostic value of p53 overexpression in breast cancer patients treated with a modified radical mastectomy and show that p53 over-expression is correlated with breast cancer-specific death rates and adverse prognostic factors.
Journal ArticleDOI
Synergistic effect between celecoxib and luteolin is dependent on estrogen receptor in human breast cancer cells
TL;DR: The synergistic anti-tumor effect of the celecoxib and luteolin combination treatment in different four breast cancer cell lines is demonstrated, thus introducing the possibility of this combination as a new treatment modality.